The performance of companies tied to blockbuster drugs like Viagra presents a nuanced investment scenario . While the initial boom of copyright, fueled by Viagra's extraordinary popularity, generated substantial returns, the patent expiration in key regions has introduced considerable volatility. Investors are now grappling with the effect of rival